58 results
8-K
EX-1.1
OGEN
Oragenics Inc
1 Mar 24
Oragenics Announces Closing of Public Offering
4:05pm
in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of any governmental
424B5
OGEN
Oragenics Inc
29 Feb 24
Prospectus supplement for primary offering
4:41pm
of supply, and the loss of this supplier could significantly harm our business.
ONP-002 is a fully synthetic, non-naturally occurring neurosteroid … in place for a redundant or second-source supply of any products or substances in the event our current supplier ceases their operations or stops offering
424B5
OGEN
Oragenics Inc
27 Feb 24
Prospectus supplement for primary offering
5:04pm
and financial condition.
The third party upon whom we rely for the supply of ONP-002 is our sole source of supply, and the loss of this supplier … supply of any products or substances in the event our current supplier ceases their operations or stops offering us sufficient quantities
8-K
OGEN
Oragenics Inc
16 Jan 24
Other Events
9:10am
sole source of supply, and the loss of this supplier could significantly harm our business.
ONP-002 is a fully synthetic, non-naturally occurring … have arrangements in place for a redundant or second-source supply of any products or substances in the event our current supplier ceases
424B5
orc5i9z5pe8oo9oxm1oa
16 Jan 24
Prospectus supplement for primary offering
9:04am
8-K
EX-2.1
b8hbaha7hf7ta
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-1.1
85ojyz8awwwzf7938p
1 Feb 21
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-1.1
iyn72a8j2ecg
24 Nov 20
Oragenics Announces Closing of $6.0 Million Underwritten Public Offering
11:59am
8-K
EX-10.1
hikr9o18
4 May 20
Entry into a Material Definitive Agreement
7:00am
424B4
aggc 69nmu
13 Jul 18
Prospectus supplement with pricing info
4:03pm